Variant report
Variant | esv3331780 |
---|---|
Chromosome Location | chr1:191544954-191547377 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370468982 | chr1:191544985-191544986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72727104 | chr1:191544992-191544993 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs541348349 | chr1:191544994-191544995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192878754 | chr1:191545025-191545026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533199981 | chr1:191545036-191545037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140072129 | chr1:191545061-191545062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562651652 | chr1:191545072-191545073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531571589 | chr1:191545097-191545098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548194658 | chr1:191545125-191545126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572004288 | chr1:191545160-191545161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185046490 | chr1:191545165-191545166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527957934 | chr1:191545197-191545198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548117692 | chr1:191545285-191545286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201507972 | chr1:191545336-191545337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570950125 | chr1:191545413-191545414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187807530 | chr1:191545463-191545464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150306624 | chr1:191545569-191545570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538955347 | chr1:191545633-191545634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554393000 | chr1:191545681-191545682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572554944 | chr1:191545701-191545702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569788219 | chr1:191545703-191545704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138311526 | chr1:191545712-191545713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560668999 | chr1:191545730-191545731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572034005 | chr1:191545831-191545832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558795639 | chr1:191545970-191545971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs199698415 | chr1:191545989-191545990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374693571 | chr1:191545990-191545991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369756051 | chr1:191545994-191545995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373529902 | chr1:191545997-191545998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77244553 | chr1:191546002-191546003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192423310 | chr1:191546012-191546013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115820346 | chr1:191546021-191546022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77361135 | chr1:191546035-191546036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558071738 | chr1:191546061-191546062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577722696 | chr1:191546062-191546063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543236374 | chr1:191546118-191546119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs68072836 | chr1:191546131-191546132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183849781 | chr1:191546155-191546156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554040117 | chr1:191546162-191546163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546107534 | chr1:191546167-191546168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143060469 | chr1:191546185-191546186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541949057 | chr1:191546228-191546229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531920144 | chr1:191546231-191546232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561934645 | chr1:191546239-191546240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145085533 | chr1:191546244-191546245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371630373 | chr1:191546248-191546249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562147831 | chr1:191546253-191546254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548280547 | chr1:191546258-191546259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188991292 | chr1:191546365-191546366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181598128 | chr1:191546410-191546411 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:191542600-191545000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:191544200-191545000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr1:191544200-191545000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr1:191544200-191545000 | Enhancers | NH-A | brain |
5 | chr1:191544400-191545200 | Enhancers | Ovary | ovary |
6 | chr1:191544400-191545400 | Enhancers | K562 | blood |
7 | chr1:191544800-191545600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr1:191545000-191545400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr1:191545000-191545400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr1:191545000-191545400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr1:191545000-191545400 | Enhancers | Fetal Kidney | kidney |
12 | chr1:191545000-191545600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr1:191545400-191546600 | Weak transcription | K562 | blood |
14 | chr1:191545600-191546400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr1:191546400-191550400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr1:191546600-191546800 | Enhancers | K562 | blood |